These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 18243838

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Epidemiology, natural history, and risk factors of hepatocellular carcinoma].
    Fares N, Péron JM.
    Rev Prat; 2013 Feb; 63(2):216-7, 220-2. PubMed ID: 23513788
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Management of hepatocellular carcinoma].
    Pache I, Bize P, Halkic N, Montemurro M, Giostra E, Majno P, Moradpour D.
    Rev Med Suisse; 2010 Jan 27; 6(233):198-202. PubMed ID: 20214192
    [Abstract] [Full Text] [Related]

  • 6. Hepatocellular carcinoma.
    Desjardins LA.
    Clin J Oncol Nurs; 2002 Jan 27; 6(2):107-8. PubMed ID: 11889672
    [Abstract] [Full Text] [Related]

  • 7. [Hepatocellular carcinoma--epidemiology and treatment].
    Małkowski P, Pacholczyk M, Łagiewska B, Adadyński L, Wasiak D, Kwiatkowski A, Chmura A, Czerwiński J.
    Przegl Epidemiol; 2006 Jan 27; 60(4):731-40. PubMed ID: 17682755
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Current therapeutic strategies in hepatocellular carcinoma, Part 1].
    Wallner I, Hartmann H, Ramadori G.
    Leber Magen Darm; 1994 Jul 27; 24(4):150, 153-4. PubMed ID: 7934608
    [Abstract] [Full Text] [Related]

  • 11. [Epidemiology, natural history and pathogenesis of hepatocellular carcinoma].
    Maillard E.
    Cancer Radiother; 2011 Feb 27; 15(1):3-6. PubMed ID: 21239205
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK.
    J Nucl Med; 2009 Jun 27; 50(6):871-7. PubMed ID: 19443599
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Hepatocellular carcinoma].
    Andersen IB, Sørensen TI, Krogsgaard K.
    Ugeskr Laeger; 1989 Feb 27; 151(9):550-3. PubMed ID: 2538017
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
    Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA.
    Mutat Res; 2008 Feb 27; 659(1-2):176-84. PubMed ID: 18346933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.